These analysts review their expectations after the first quarter profits – CELESE: CLS)

Celestica Inc CLS Doveings were reported in the first quarter of the expected after the closing bell on Thursday.
The company recorded revenues of $ 2.65 billion, for estimates of $ 2.61 billion. The modified profits came at $ 1.20 per share, for estimates of $ 1.15 per share.
“Celestica achieved the first powerful quarter in 2025, with revenues of $ 2.65 billion, raising the profitability of the unjustified arrow in GAAP, at a value of $ 1.20, exceeding the high side in our direction ranges. This strong performance was highlighted by the highest rate of operation of an average rate of 7.1 %.”
Celestica went to the second -quarter revenue from $ 2.58 billion to $ 2.73 billion for $ 2.77 billion. The company expects that the profits modified in the second quarter will be in the range of $ 1.17 to $ 1.27 per share for Benzinga Pro estimates of $ 1.24 per share.
The company also raised its expectations for the entire year of 2025. Celestica raised its revenues for the entire year from 10.7 billion dollars to 10.85 billion dollars, and raised its profits from $ 4.75 per share to $ 5 per share. The guidance is still less than $ 12.54 billion of analysts’ estimates of revenues and profits of $ 5.76 per share.
Cilestica shares fell by 3.3 % trading at $ 86.13 on Monday.
These analysts have made changes to their price goals on Celestica after announcing the profits.
- George Wang, Barccelic analyst, maintained CelceCa to classify weight gain and reduce the target price from $ 157 to $ 126.
- JP Morgan Samik Chatterje, with Celistica, maintains weight gain and raised the target price from $ 105 to $ 115.
- Meanwhile, the RBC Capital Paul Treiber analyst remedy the stock classification and maintained a $ 120 target price.
Looking at the purchase of CLS stocks? This is what analysts believe:
Read this following:
Photo via Shutterstock
Market news and data brought to you benzinga Apis
© 2025 benzinga.com. Benzinga does not provide investment advice. All rights reserved.